Further adjustment for a history of myocardial infarction, stroke, heart failure, diabetes, and medication for hypertension, diabetes or hyperlipidaemia only had a marginal effect on the correlations between AhR bioactivity and TEQ or individual POPs. The gene discussed is AHR; the disease is hyperlipidemia.